Europe Micro Invasive Glaucoma Surgery (MIGS) Devices Market - Industry Trends and Forecast to 2030
The Europe micro invasive glaucoma surgery (MIGS) devices market is expected to reach USD 1,738.15 million by 2030 from USD 221.19 million in 2022, growing at the CAGR of 29.7% in the forecast period of 2023 to 2030.
Market Segmentation
Europe Micro Invasive Glaucoma Surgery (MIGS) Devices Market, By Product Type (MIGS Shunt, MIGS Stent, Trabectome, Kahook Dual Blade, Tube Shunt, Micro-Implants, Micro Catheters, and Others), Target (Trabecular Meshwork, Suprachoroidal Space, Subconjunctival Filtration, Reducing Aqueous Production, and Others), Surgery Type (Glaucoma in Conjunction with Cataract and Stand-Alone Glaucoma), Glaucoma Type (Open Angle Glaucoma, Acute- Angle Glaucoma, Normal Tension Glaucoma, Secondary Glaucoma, Pigmentary Glaucoma, and Congenital Glaucoma), End User (Hospital, Ophthalmology Clinics, Ambulatory Surgery Centers (ASCS), and Others), Distribution Channel (Direct Tenders, Retail Sales, and Others), Country (Germany, U.K., France, Italy, Russia, Spain, Turkey, Switzerland, Netherlands, Belgium, Denmark, Poland, Sweden, Norway, Finland, and Rest of Europe) - Industry Trends and Forecast to 2030
Overview of Europe Micro Invasive Glaucoma Surgery (MIGS) Devices Market Dynamics
Driver
• Increase in the geriatric population
Restraint
• Stringent regulations for Micro Invasive Glaucoma Surgery (MIGS) devices
Opportunity
• Rapid transition from glaucoma medication to minimally invasive glaucoma surgeries
Market Players
Some of the key market players operating in the Europe micro invasive glaucoma surgery (MIGS) devices market are:
• Glaukos Corporation
• AbbVie
• Alcon
• Johnson & Johnson Vision Care, Inc.
• Sight Sciences, Inc.
• Santen SA
• iSTAR Medical
• BVI
• Lumibird Medical Nordics AB
• Oertli Instrumente AG
• NOVAEYE MEDICAL
• Lumenis Be Ltd.
• Inami & CO.,Ltd